Biogen Switzerland AG - Vumerity 231 mg, Magensaftresistente Hartkapseln | | 68066 | | 01 | | Vumerity 231 mg | | Magensaftresistente Hartkapseln | | L04AX09 | | Diroximel Fumarate | | 20.09.2021 | | |
| Composition | diroximeli fumaras 231 mg, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, crospovidonum, cellulosum microcristallinum, silica colloidalis anhydrica, triethylis citras, talcum, magnesii stearas, Kapselhülle: hypromellosum, E 171, kalii chloridum, carrageenanum, aqua, Drucktinte: lacca, propylenglycolum, ammoniae solutio 30 per centum, E 172 (nigrum), kalii hydroxidum pro capsula. | Packungsbestandteile | | Capsules resistantes à suc gastrique | | | Principe actif | Concentr. |
---|
Diroximeli Fumaras | 231 mg |
| BAG: Principe actif | Concentr. |
---|
Diroximeli Fumaras | 231 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
(Nigrum) | | | Acidi Methacrylici | | | Ammoniae Solutio | 30 | | Aqua | | | Carrageenanum | | | Cellulosum Microcristallinum | | | Crospovidonum | | | E 171 | | color. | E 172 | | color. | Ethylis Acrylatis Polymerisatum | | | Hypromellosum | | Kapselhülle | Potassium Chlorure | | | Kalii Hydroxidum pro Capsula | | | Lacca | | Drucktinte | Magnesii Stearas | | | Per Centum | | | Propylenglycol | | | Silica Colloidalis Anhydrica | | | Talcum | | | Triethylis Citras | | |
| |
| |
|